251 related articles for article (PubMed ID: 21803058)
1. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Morales-Medina JC; Dumont Y; Benoit CE; Bastianetto S; Flores G; Fournier A; Quirion R
Neuropharmacology; 2012 Jan; 62(1):200-8. PubMed ID: 21803058
[TBL] [Abstract][Full Text] [Related]
2. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat.
Morales-Medina JC; Dominguez-Lopez S; Gobbi G; Beck-Sickinger AG; Quirion R
Behav Brain Res; 2012 Aug; 233(2):298-304. PubMed ID: 22613731
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat.
Morales-Medina JC; Dumont Y; Bonaventure P; Quirion R
Neuropeptides; 2012 Dec; 46(6):329-34. PubMed ID: 23103057
[TBL] [Abstract][Full Text] [Related]
7. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
Sato H; Skelin I; Debonnel G; Diksic M
Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
[TBL] [Abstract][Full Text] [Related]
8. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
9. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Redrobe JP; Dumont Y; Fournier A; Quirion R
Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
[TBL] [Abstract][Full Text] [Related]
10. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
Kokare DM; Dandekar MP; Chopde CT; Subhedar N
Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
[TBL] [Abstract][Full Text] [Related]
11. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
[TBL] [Abstract][Full Text] [Related]
12. Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.
Hendriksen H; Meulendijks D; Douma TN; Bink DI; Breuer ME; Westphal KG; Olivier B; Oosting RS
Neuropharmacology; 2012 Jan; 62(1):270-7. PubMed ID: 21807004
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
[TBL] [Abstract][Full Text] [Related]
14. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
[TBL] [Abstract][Full Text] [Related]
15. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
[TBL] [Abstract][Full Text] [Related]
16. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
17. Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model.
Serova LI; Laukova M; Alaluf LG; Pucillo L; Sabban EL
Eur Neuropsychopharmacol; 2014 Jan; 24(1):142-7. PubMed ID: 24326087
[TBL] [Abstract][Full Text] [Related]
18. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A
J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263
[TBL] [Abstract][Full Text] [Related]
19. Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.
Wang YQ; Tu ZC; Xu XY; Li R; Qu WM; Urade Y; Huang ZL
J Neurochem; 2012 Jan; 120(2):314-24. PubMed ID: 22035172
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
